Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Das Gupta, Jaydip ^a   Luk, Ka Cheung ^b   Tang, Ning ^c   Gaughan, Christina ^a   Klein, Eric A ^a   Kandel, Eugene S ^d   Hackett, John ^b   Silverman, Robert H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c Abbott Molecular Inc   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PRIMER DNA; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL STRAIN 22RV1; CONTROLLED STUDY; DNA DETERMINATION; EXCISION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS RECOMBINATION; XENOTROPIC MULV RELATED VIRUS; GENETICS; ISOLATION AND PURIFICATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE; VIROLOGY;

MURINE LEUKEMIA VIRUS; MUS; MUS MUSCULUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; DNA, VIRAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84861209863     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036072     Document Type: Article

References (50)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant. PLoS Pathog 2: e25.
2. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR, (2009) XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A 106: 16351-16356.
3. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, et al. (2010) XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 75: 755-761.
4. Danielson BP, Ayala GE, Kimata JT, (2010) Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis 202: 1470-1477.
5. Kim S, Kim N, Dong B, Boren D, Lee SA, et al. (2008) Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 82: 9964-9977.
6. Hong S, Klein EA, Das Gupta J, Hanke K, Weight CJ, et al. (2009) Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol 83: 6995-7003.
7. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, et al. (2009) Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6: 92.
8. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, et al. (2008) Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 43: 277-283.
9. D'Arcy F, Foley R, Perry A, Marignol L, Lawler M, et al. (2008) No evidence of XMRV in Irish prostate cancer patients with R462Q mutation. European Urology (Suppl 7): 271.
10. Verhaegh GW, de Jong AS, Smit FP, Jannink SA, Melchers WJ, et al. (2011) Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients. Prostate 71: 415-420.
11. Switzer WM, Jia H, Zheng H, Tang S, Heneine W, (2011) No association of xenotropic murine leukemia virus-related viruse with prostate cancer. PLoS ONE 6: e19065.
12. Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, et al. (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68: 306-320.
13. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, et al. (2010) XMRV: A New Virus in Prostate Cancer? Cancer Res 70: 10028-10033.
14. Stieler K, Schindler S, Schlomm T, Hohn O, Bannert N, et al. (2011) No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe. PLoS ONE 6: e25592.
15. Sakuma T, Hue S, Squillace KA, Tonne JM, Blackburn PR, et al. (2011) No evidence of XMRV in prostate cancer cohorts in the Midwestern United States. Retrovirology 8: 23.
16. Furuta RA, Miyazawa T, Sugiyama T, Kuratsune H, Ikeda Y, et al. (2011) No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology 8: 20.
17. Rusmevichientong A, Das Gupta J, Elias PS, Silverman RH, Chow SA, (2011) Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus. J Virol 85: 12830-12834.
18. Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, et al. (2010) Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 7: 108.
19. Sato E, Furuta RA, Miyazawa T, (2010) An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 7: 110.
20. Erlwein O, Robinson MJ, Dustan S, Weber J, Kaye S, et al. (2011) DNA extraction columns contaminated with murine sequences. PLoS ONE 6: e23484.
21. Silverman RH, Nguyen C, Weight CJ, Klein EA, (2010) The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nat Rev Urol 7: 392-402.
22. Tuke PW, Tettmar KI, Tamuri A, Stoye JP, Tedder RS, (2011) PCR master mixes harbour murine DNA sequences. Caveat emptor! PLoS ONE 6: e19953.
23. Bacich DJ, Sobek KM, Cummings JL, Atwood AA, O'Keefe DS, (2011) False negative results from using common PCR reagents. BMC Res Notes 4: 457.
24. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
25. Silverman RH, Das Gupta J, Lombardi VC, Ruscetti FW, Pfost MA, et al. (2011) Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 334: 176.
26. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, et al. (2011) No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 333: 94-97.
27. Shin CH, Bateman L, Schlaberg R, Bunker AM, Leonard CJ, et al. (2011) Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome. J Virol 85: 7195-7202.
28. Alberts B, (2011) Retraction. Science 334: 1636.
29. Dodd RY, Hackett J Jr, Linnen JM, Dorsey K, Wu Y, et al. (2011) Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety. Transfusion 52: 298-306.
30. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, et al. (2011) Recombinant Origin of the Retrovirus XMRV. Science 333: 97-101.
31. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, et al. (2009) Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 83: 7353-7356.
32. Pretlow TG, Wolman SR, Micale MA, Pelley RJ, Kursh ED, et al. (1993) Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst 85: 394-398.
33. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, et al. (1996) CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 56: 3042-3046.
34. Sramkoski RM, Pretlow TG 2nd, Giaconia JM, Pretlow TP, Schwartz S, et al. (1999) A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim 35: 403-409.
35. Yang J, Battacharya P, Singhal R, Kandel ES, (2011) Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact. Oncotarget 2: 358-362.
36. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, et al. (2007) An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 104: 1655-1660.
37. Tang N, Frank A, Leckie G, Hackett J Jr, Simmons G, et al. (2012) Development of sensitive single-round pol or env RT-PCR assays to screen for XMRV in multiple sample types. J Virol Methods 179: 127-134.
38. Bittner ML, Morrison LE, Legator MS, (1996) Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture. United States Patent 5, 491, 224 Washington DC:United States Government Printing Office.
39. Morrison LE, Ramakrishnam R, Ruffalo TM, Wilber KA, (2003) Labeling fluorescence in situ hybridization probes for genomic targets. In: Fan, YS (ed) Methods in Molecular Biology 204: Molecular cytogenetics:protocols and applications. Humana Press, New Jersey, 21-40.
40. Braun A, Little DP, Koster H, (1997) Detecting CFTR gene mutations by using primer oligo base extension and mass spectrometry. Clin Chem 43: 1151-1158.
41. Ymer S, Tucker WQ, Campbell HD, Young IG, (1986) Nucleotide sequence of the intracisternal A-particle genome inserted 5′ to the interleukin-3 gene of the leukemia cell line WEHI-3B. Nucleic Acids Res 14: 5901-5918.
42. Stoye JP, Coffin JM, (1988) Polymorphism of murine endogenous proviruses revealed by using virus class-specific oligonucleotide probes. J Virol 62: 168-175.
43. Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, et al. (2011) The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans. Transfusion 51: 643-653.
44. Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, et al. (2011) Infection, Viral Dissemination, and Antibody Responses of Rhesus Macaques Exposed to the Human Gammaretrovirus XMRV. J Virol 85: 4547-4557.
45. Del Prete GQ, Kearney MF, Spindle, J, Wiegand A, Chertova E, et al. (2012) Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques. J Virol 86: 3152-3166.
46. Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, et al. (2010) Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol 84: 5719-5729.
47. Stieler K, Fischer N, (2010) Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS ONE 5: e11738.
48. Dong B, Silverman RH, (2010) Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus. J Virol 84: 1648-1651.
49. Rodriguez JJ, Goff SP, (2010) Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J Virol 84: 2556-2562.
50. Pandhare-Dash J, Mantri CK, Gong Y, Chen Z, Dash C, (2011) XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1). Prostate. [Epub ahead of print].